Howard Berman
Board Member
Atea Pharmaceuticals, Inc. (AVIR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-01-01–present
-
2020-01-01–2026-04-01
-
2020-01-01–2026-04-01
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Coya Therapeutics, Inc. (COYA) | Former Chief Executive Officer, Former Executive Chairman of the Board | $436,800 | $1,471,701 |
| 2024 | Coya Therapeutics, Inc. (COYA) | Former Chief Executive Officer, Current Executive Chairman of the Board | $553,333 | $2,680,268 |
| 2023 | Coya Therapeutics, Inc. (COYA) | Former Chief Executive Officer, Current Executive Chairman of the Board | $580,000 | $1,317,200 |
| 2022 | Coya Therapeutics, Inc. (COYA) | Chief Executive Officer | $412,500 | $598,125 |
| 2021 | Coya Therapeutics, Inc. (COYA) | Chief Executive Officer | $300,000 | $390,000 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.